Company Overview

Update
Founded:
2012
Headquarters:
Lincoln, MA
Funding:
$26M
Categories:
Biotechnology
Description:
Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.

Detailed Description

Update

Cydan is an orphan drug accelerator that identifies and de-risks compounds with therapeutic and commercial potential. Their rigorous process generates data to support a development path and new company formation. Cydan’s experienced and globally networked team brings strong relationships with academia and patient advocacy, deep expertise in drug development, and a track record of successful product commercialization.

Board Members and Advisors (1)

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Office

    16 Conant Road

    Lincoln, MA 01773

    USA

Images (1)

Update
  • 575485acd1bf38e70437bed774f02232